These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 33367495)

  • 61. Concurrent acute myeloid leukemia and T lymphoblastic lymphoma in a patient with rearranged PDGFRB genes.
    Chang H; Chuang WY; Sun CF; Barnard MR
    Diagn Pathol; 2012 Feb; 7():19. PubMed ID: 22356850
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Quantification of PDGFRA alternative transcripts improves the screening for X-PDGFRA fusions by reverse transcriptase-polymerase chain reaction.
    Erquiaga I; Ormazábal C; Hurtado C; Aranaz P; Calasanz MJ; García-Delgado M; Novo FJ; Vizmanos JL
    Leuk Lymphoma; 2010 Sep; 51(9):1720-6. PubMed ID: 20615084
    [TBL] [Abstract][Full Text] [Related]  

  • 63. T-lymphoblastic lymphoma and acute myeloid leukaemia transformed from myeloid neoplasm with eosinophilia: a divergent evolution of myeloid neoplasm with monosomy 7 but no detectable tyrosine kinase gene rearrangements designated by the WHO Classification.
    Yang LH; Zhao Y; Maule J; Rapisardo S; Wang E
    Br J Haematol; 2020 Sep; 190(5):e307-e312. PubMed ID: 32525559
    [No Abstract]   [Full Text] [Related]  

  • 64. Identification of a Novel CSNK2A1-PDGFRB Fusion Gene in a Patient with Myeloid Neoplasm with Eosinophilia.
    Xu X; Lu Q; Wang Z; Cai P; Zeng Z; Zhang L; Wang M; Ma L; Ruan C; Chen S
    Cancer Res Treat; 2021 Jul; 53(3):889-892. PubMed ID: 33421986
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Genomic analysis of clonal eosinophils by CGH arrays reveals new genetic regions involved in chronic eosinophilia.
    Arefi M; Robledo C; Peñarrubia MJ; García de Coca A; Cordero M; Hernández-Rivas JM; García JL
    Eur J Haematol; 2014 Nov; 93(5):422-8. PubMed ID: 24813417
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Integrated genomic analysis using chromosomal microarray, fluorescence in situ hybridization and mate pair analyses: Characterization of a cryptic t(9;22)(p24.1;q11.2)/BCR-JAK2 in myeloid/lymphoid neoplasm with eosinophilia.
    Snider JS; Znoyko I; Lindsey KG; Morse J; Baughn LB; Hoppman NL; Pitel BA; Pearce KE; Schandl CA; Wolff DJ
    Cancer Genet; 2020 Aug; 246-247():44-47. PubMed ID: 32827877
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Myeloid/Lymphoid Neoplasm with PDGFRB Rearrangement with t (5;10) (q33;q22) Harboring a Novel Breakpoint of the CCDC6-PDGFRB Fusion Gene.
    Yamazaki M; Nakaseko C; Takeuchi M; Ozawa S; Ishizuka Y; Hatanaka Y; Oshima-Hasegawa N; Muto T; Tsukamoto S; Mitsukawa S; Ohwada C; Takeda Y; Mimura N; Iseki T; Fukazawa M; Sakaida E
    Intern Med; 2019 Dec; 58(23):3449-3453. PubMed ID: 31327842
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A tricky and rare cause of pulmonary eosinophilia: myeloid/lymphoid neoplasm with eosinophilia and rearrangement of PDGFRA.
    Zanelli M; Smith M; Zizzo M; Carloni A; Valli R; De Marco L; Foroni M; Palicelli A; Martino G; Ascani S
    BMC Pulm Med; 2019 Nov; 19(1):216. PubMed ID: 31744552
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Update on CML-Like Disorders.
    Cross NCP
    Clin Lymphoma Myeloma Leuk; 2020 Sep; 20 Suppl 1():S101-S102. PubMed ID: 32862848
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Recurrent CEP85L-PDGFRB fusion in patient with t(5;6) and imatinib-responsive myeloproliferative neoplasm with eosinophilia.
    Winkelmann N; Hidalgo-Curtis C; Waghorn K; Score J; Dickinson H; Jack A; Ali S; Cross NC
    Leuk Lymphoma; 2013 Jul; 54(7):1527-31. PubMed ID: 23186533
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Five years since the discovery of FIP1L1-PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias.
    Gotlib J; Cools J
    Leukemia; 2008 Nov; 22(11):1999-2010. PubMed ID: 18843283
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A Case of a Very Young Child With T Lymphoblastic Lymphoma With Eosinophilia and PDGFRB Translocation: A Rare Form of Myeloid/Lymphoid Neoplasm Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB or FGFR1.
    Grimes AB; Miller MB; Elghetany MT; Marcogliese AN; Schafer ES
    Clin Lymphoma Myeloma Leuk; 2020 Dec; 20(12):e990-e993. PubMed ID: 32921591
    [No Abstract]   [Full Text] [Related]  

  • 73. World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management.
    Gotlib J
    Am J Hematol; 2014 Mar; 89(3):325-37. PubMed ID: 24577808
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Complete response of myeloid sarcoma with FIP1L1-PDGFRA -associated myeloproliferative neoplasms to imatinib mesylate monotherapy.
    Tang TC; Chang H; Chuang WY
    Acta Haematol; 2012; 128(2):83-7. PubMed ID: 22722648
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Molecular analysis of PDGFRalpha/beta genes in core binding factor leukemia with eosinophilia.
    Monma F; Nishii K; Lorenzo F; Usui E; Ueda Y; Watanabe Y; Kawakami K; Oka K; Mitani H; Sekine T; Tamaki S; Mizutani M; Yagasaki F; Doki N; Miyawaki S; Katayama N; Shiku H
    Eur J Haematol; 2006 Jan; 76(1):18-22. PubMed ID: 16343267
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Myeloproliferative neoplasm with eosinophilia and coexisting BCR::ABL1 and PDGFRB rearrangement: favorable and rapid response to imatinib.
    Yao S; Na L; Liangding H
    Ann Hematol; 2024 Aug; 103(8):3247-3250. PubMed ID: 38888615
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A complex and cryptic intrachromosomal rearrangement generating the FIP1L1_PDGFRA in adult acute myeloid leukemia.
    Coccaro N; Anelli L; Orsini P; Zagaria A; Minervini A; Impera L; Tota G; Minervini CF; Cumbo C; Parciante E; Coserva MR; Attolico I; Specchia G; Albano F
    Cancer Genet; 2019 Nov; 239():8-12. PubMed ID: 31450116
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Synoptic Diagnostics of Myeloproliferative Neoplasms: Morphology and Molecular Genetics.
    Nann D; Fend F
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298741
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Eosinophilic myeloid disorders: new classification and novel therapeutic strategies.
    Gotlib J
    Curr Opin Hematol; 2010 Mar; 17(2):117-24. PubMed ID: 20071982
    [TBL] [Abstract][Full Text] [Related]  

  • 80. SOHO State of the Art Updates and Next Questions | Myeloid/Lymphoid Neoplasms with Eosinophilia and Gene Rearrangements: Diagnostic Pearls and Pitfalls.
    Kim AS; Pozdnyakova O
    Clin Lymphoma Myeloma Leuk; 2022 Sep; 22(9):643-651. PubMed ID: 35478091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.